Global Patent Index - EP 1328535 B1

EP 1328535 B1 20070815 - MACROLIDES

Title (en)

MACROLIDES

Title (de)

MAKROLIDE

Title (fr)

MACROLIDES

Publication

EP 1328535 B1 20070815 (EN)

Application

EP 01982656 A 20011019

Priority

  • GB 0025688 A 20001019
  • IB 0102167 W 20011019

Abstract (en)

[origin: WO0232917A1] The present invention relates to a compound of formula (I) wherein R1 is hydrogen or together with R2 is oxo; R2 represents hydroxy, OC(O)XR7, OC(O)NHXR7 or R2 together with R1 is an oxo group; R3 is hydrogen or a hydroxyl protecting group; R4 is hydrogen or XR7; R5 is hydrogen, XR7 or C(O)NHXR7; R6 is hydrogen or R5 and R6 taken together with the intervening atoms form a cyclic carbonate having the following structure and pharmaceutically acceptable salts and solvates thereof and solvates thereof; to processes for their preparation and their use in the therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.

IPC 8 full level

C07H 17/08 (2006.01); A61K 31/70 (2006.01); A61K 31/7048 (2006.01); A61P 31/04 (2006.01); C07B 61/00 (2006.01)

CPC (source: EP US)

A61P 31/04 (2017.12 - EP); C07H 17/08 (2013.01 - EP US); Y02P 20/55 (2015.11 - EP US)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0232917 A1 20020425; AT E370156 T1 20070915; AU 1419702 A 20020429; DE 60130009 D1 20070927; DE 60130009 T2 20080508; EP 1328535 A1 20030723; EP 1328535 B1 20070815; ES 2291366 T3 20080301; GB 0025688 D0 20001206; JP 2004511566 A 20040415; US 2004254124 A1 20041216; US 7262172 B2 20070828

DOCDB simple family (application)

IB 0102167 W 20011019; AT 01982656 T 20011019; AU 1419702 A 20011019; DE 60130009 T 20011019; EP 01982656 A 20011019; ES 01982656 T 20011019; GB 0025688 A 20001019; JP 2002536298 A 20011019; US 39942604 A 20040225